The Gene: An Intimate History - Siddhartha Mukherjee Page 0,262

in the gene MECP2: Antonio M. Persico and Valerio Napolioni, “Autism genetics,” Behavioural Brain Research 251 (2013): 95–112; and Guillaume Huguet, Elodie Ey, and Thomas Bourgeron, “The genetic landscapes of autism spectrum disorders,” Annual Review of Genomics and Human Genetics 14 (2013): 191–213.

the eventual effects of these gene-environment: Albert H. C. Wong, Irving I. Gottesman, and Arturas Petronis, “Phenotypic differences in genetically identical organisms: The epigenetic perspective,” Human Molecular Genetics 14, suppl. 1 (2005): R11–R18. Also see Nicholas J. Roberts et al., “The predictive capacity of personal genome sequencing,” Science Translational Medicine 4, no. 133 (2012): 133ra58.

an article in Nature magazine announced: Alan H. Handyside et al., “Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification,” Nature 344, no. 6268 (1990): 768–70.

As the political theorist Desmond King puts it: D. King, “The state of eugenics,” New Statesman & Society 25 (1995): 25–26.

Take, for instance, a series of startlingly provocative: K. P. Lesch et al., “Association of anxiety-related traits with a polymorphism in the serotonergic transporter gene regulatory region,” Science 274 (1996): 1527–31.

the short allele has been associated with: Douglas F. Levinson, “The genetics of depression: A review,” Biological Psychiatry 60, no. 2 (2006): 84–92.

In 2010, a team of researchers launched: “Strong African American Families Program,” Blueprints for Healthy Youth Development, blueprintsprograms/evaluationAbstracts.php?pid=f76b2ea6b45eff3bc8e4399145cc17a0601f5c8d.

Six hundred African-American families with early-adolescent: Gene H. Brody et al., “Prevention effects moderate the association of 5-HTTLPR and youth risk behavior initiation: Gene × environment hypotheses tested via a randomized prevention design,” Child Development 80, no. 3 (2009): 645–61; and Gene H. Brody, Yi-fu Chen, and Steven R. H. Beach, “Differential susceptibility to prevention: GABAergic, dopaminergic, and multilocus effects,” Journal of Child Psychology and Psychiatry 54, no. 8 (2013): 863–71.

Writing in the New York Times in 2014: Jay Belsky, “The downside of resilience,” New York Times, November 28, 2014.

“a technology of abnormal individuals”: Michel Foucault, Abnormal: Lectures at the Collège de France, 1974–1975, vol. 2 (New York: Macmillan, 2007).

Genetic Therapies: Post-Human

There is in biology at the moment: “Biology’s Big Bang,” Economist, June 14, 2007.

a journalist visited James Watson at: Lyon and Gorner, Altered Fates, 537.

Jesse Gelsinger’s “biotech death”: Stolberg, “Biotech death of Jesse Gelsinger,” 136–40.

In 2014, a landmark study: Amit C. Nathwani et al., “Long-term safety and efficacy of factor IX gene therapy in hemophilia B,” New England Journal of Medicine 371, no. 21 (2014): 1994–2004.

In 1998, soon after Thomson’s paper: James A. Thomson et al., “Embryonic stem cell lines derived from human blastocysts,” Science 282, no. 5391 (1998): 1145–47.

President George W. Bush sharply restricted: Dorothy C. Wertz, “Embryo and stem cell research in the United States: History and politics,” Gene Therapy 9, no. 11 (2002): 674–78.

Doudna and Charpentier published their data: Martin Jinek et al., “A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity,” Science 337, no. 6096 (2012): 816–21.

this technique has exploded: Key contributors to the use of CRISPR/Cas9 in human cells include Feng Zhang (MIT) and George Church (Harvard). See, for instance, L. Cong et al., “Multiplex genome engineering using CRISPR/Cas systems,” Science 339, no. 6121 (2013): 819–23; and F. A. Ran, “Genome engineering using the CRISPR-Cas9 system,” Nature Protocols 11 (2013): 2281–308.

In the winter of 2014, a team: Walfred W. C. Tang et al., “A unique gene regulatory network resets the human germline epigenome for development,” Cell 161, no. 6 (2015): 1453–67; and “In a first, Weizmann Institute and Cambridge University scientists create human primordial germ cells,” Weizmann Institute of Science, December 24, 2014, newswise/articles/in-a-first-weizmann-institute-and-cambridge-university-scientists-create-human-primordial-germ-cells.

Jennifer Doudna and David Baltimore: B. D. Baltimore et al., “A prudent path forward for genomic engineering and germline gene modification,” Science 348, no. 6230 (2015): 36–38; and Cormac Sheridan, “CRISPR germline editing reverberates through biotech industry,” Nature Biotechnology 33, no. 5 (2015): 431–32.

“It is very clear that people will try”: Nicholas Wade, “Scientists seek ban on method of editing the human genome,” New York Times, March 19, 2015.

“This reality means”: Francis Collins, Letter to the author, October 2015.

In the spring of 2015, a laboratory: David Cyranoski and Sara Reardon, “Chinese scientists genetically modify human embryos,” Nature (April 22, 2015).

The highest-ranking scientific journals: Chris Gyngell and Julian Savulescu, “The moral imperative to research editing embryos: The need to modify nature and science,” Oxford University, April 23, 2015, Blog.Practicalethics.Ox.Ac.Uk/2015/04/the-Moral-Imperative-to-Research-Editing-Embryos-the-Need-to-Modify-Nature-and-Science/.

the results were eventually published in: Puping Liang et al., “CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes,” Protein & Cell 6, no. 5 (2015): 1–10.

“planning to decrease the number of off-target”: Cyranoski and Reardon, “Chinese scientists genetically modify human embryos.”

“I don’t think China wants”: Didi Kristen Tatlow, “A scientific ethical divide between